Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

Ro 25-6981 hydrochloride

 

 

 

 

CAS169274-78-6 (free base)

C22H29NO2·HCl  MW 375.93

Purity: >99% ee de

Water soluble to 66 mM

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1314    Prime Source

 

Qty1: 10 mg / €110  $143

 

Qty2: 50 mg / €410  $533

 

Qty3: on request (in stock of multigrams)

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for payment and tech support.

Biological Activity:

 

Potent and selective antagonist of NMDA glutamate receptors containing the NR2B subunit; Optimal salt form, which is more water soluble than its maleate.

 

References: online (ref 1)

 

Fischer et al.  Ro 25-6981, a highly potent and selective blocker of N-Methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J. Pharmacol. Exp. Ther. 1997, 283, 1285.

 

 

 

 

Chemical Name:(aR,bS)-a-(4-Hydroxyphenyl)-b-methyl-4-(phenylmethyl)-1 -piperidinepropanol hydrochloride

 

Ro 25-6981 | NMDA antagonist | Axon Medchem | Ro25-6981 | Ro 256981 | Ro256981 supplier

 

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2012

 

Axon Ligands In This Field:

 

CP 101606 | NMDA antagonist

Ifenprodil | NMDA antagonist

Eliprodil | NMDA antagonist

N20C | NMDA antagonist

Gavestinel | Glycine antagonist

Ro 25-6981 | NMDA antagonist

Lamotrigine | Glutamate antago.

 

CFM-2 | AMPA antagonist

CNQX | AMPA/kanaite antagonist

DNQX | AMPA/kainate antagonist

GYKI 53655 | AMPA antagonist

YM-90K | AMPA antagonist

 

AZ 12216052 | mGluR8 PAM

BINA | mGluR2 PAM 

CPPHA | mGluR5 PAM

(S)-3,5-DHPG | mGluR1 agonist

VU-29 | mGuR5 PAM

LY 367385 | mGluR1a antagonist

YM 298198 | mGluR1 antagonist

Fenobam | mGluR5 antagonist

MPEP | mGluR5 antagonist